Related Experiment Videos
Androgen-regulated gene expression in prostate cancer
1Department of Pathology, Erasmus University, Rotterdam, The Netherlands.
Seminars in Cancer Biology
|February 1, 1997
Summary
Androgen receptor (AR) signaling drives prostate cancer growth. Despite endocrine therapy, some cancers persist, suggesting AR remains functional through mutations or ligand-independent activation in advanced prostate cancer.
Area of Science:
- Molecular Endocrinology
- Cancer Biology
- Prostate Cancer Research
Background:
- Androgen receptor (AR) signaling is crucial for male urogenital tract development and prostate cancer growth.
- Endocrine therapy targets AR to inhibit prostate cancer progression.
- AR-independent tumor growth occurs despite ongoing therapy, with AR still expressed.
Purpose of the Study:
- To investigate the role of the androgen receptor in hormone-refractory prostate cancer.
- To explore mechanisms of AR activation in late-stage prostate tumors.
Main Methods:
- Analysis of androgen receptor gene status in prostate tumors.
- Investigation of androgen receptor expression and potential activation pathways.
Main Results:
- Prostate cancers often remain androgen-dependent for growth.
- Late-stage prostate tumors can exhibit AR gene mutations or amplification.
- Ligand-independent AR activation is a potential mechanism in hormone-refractory prostate cancer.
Conclusions:
- The androgen receptor plays a significant role even in advanced, treatment-resistant prostate cancer.
- Understanding AR alterations and activation mechanisms is vital for improving prostate cancer therapy.